Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07781657 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07781657 · ClinicalTrials.gov record · last posted 2026-08-24

Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

Name: Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease — clinical trial record (NCT07781657)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TARBELA-AD

StatusNot Yet Recruiting

PhasePhase 2

SponsorHoffmann-La Roche

Started2026-10-31

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study aims to compare the effects of RO7568282 versus a placebo in people in the early stages of Alzheimer's disease (AD).

Trial Details

NCT Number	NCT07781657
Lead Sponsor	Hoffmann-La Roche
Conditions	Alzheimer's Disease
Enrollment	450 participants
Start Date	2026-10-31
Primary Completion	2029-11-01 (estimated)
Study Completion	2029-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-24